ImpediMed: Releases heart failure and renal disease software for SOZO
- ImpediMed (IPD) has released a new heart failure and renal disease software for its SOZO Digital Health Platform
- This new software, which is called HF-Dex, is also used to assess an abundance of fluid in patients with heart failure
- According to the Heart Foundation, cardiovascular disease is one of Australia’s largest health problems
- According to Kidney Health Australia, approximately 1.7 million Australian’s over the age of 18 have indicators of kidney disease
- Once a patient knows their levels, clinicians can provide individualised care to help improve outcomes
- Despite this advance, ImpediMed shares are only up a slight 2.86 per cent and trading for 3.6 cents each
